VIVO Share Price

Open 13.65 Change Price %
High 13.80 1 Day 0.05 0.37
Low 13.65 1 Week -0.05 -0.36
Close 13.70 1 Month -1.45 -9.57
Volume 103872 1 Year -5.37 -28.16
52 Week High 19.85
52 Week Low 10.75
VIVO Important Levels
Resistance 2 13.84
Resistance 1 13.78
Pivot 13.72
Support 1 13.62
Support 2 13.56
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DCTH 0.13 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.03 50.00%
LOCM 0.09 50.00%
VRTA 4.50 38.46%
ATEA 2.50 32.98%
ATEA 2.50 32.98%
KIRK 10.98 31.03%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
TWER 0.10 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Meridian Bioscience Inc. (NASDAQ: VIVO)

VIVO Technical Analysis 5
As on 22nd Aug 2017 VIVO Share Price closed @ 13.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.36 & Strong Sell for SHORT-TERM with Stoploss of 14.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIVO Target for August
1st Target up-side 14.8
2nd Target up-side 15.68
3rd Target up-side 16.56
1st Target down-side 12.3
2nd Target down-side 11.42
3rd Target down-side 10.54
VIVO Other Details
Segment EQ
Market Capital 814715968.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.meridianbioscience.com
VIVO Address
VIVO
3471 River Hills Drive
Cincinnati, OH 45244
United States
Phone: 513-271-3700
Fax: 513-271-3762
Interactive Technical Analysis Chart Meridian Bioscience Inc. ( VIVO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Meridian Bioscience Inc.
VIVO Business Profile
Meridian Bioscience, Inc. (Meridian) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics and Life Science.